All references cited herein are incorporated by reference in their entirety.
The cost of shipping products can be a significant expense for most product manufacturers. When the cost of shipping a product approaches close to and/or exceeds twenty percent (20%) of a product’s retail price, such a cost may substantially erode potential profits for the product manufacturer. Often, product manufacturers use private shipping carriers (i.e. United Parcel Service [UPS], FedEx, DHL, etc.) since private shipping carriers may provide door-to-door service.
In the United States, private shipping carriers usually charge three to five times or more in shipping costs compared to the First-Class mail rate set by the United States (U.S.) Postal Service (USPS). Generally, private shipping carriers charge more fees to deliver products to a consumer’s doorstep because private shipping carriers are not permitted to deliver products in U.S. Postal Service mailboxes.
Meanwhile, product manufacturers may significantly reduce their shipping costs compared to private shipping carriers if they can use the USPS with its First-Class mail rate and provide packages which are “machinable” as defined by the USPS. The first class mail rate (as of this writing) is $0.42 for 1.0 ounce, and $0.17 for each additional ounce as of this writing. [See https://about.usps.com/postal-bulletin/2007/html/pb22218/kit1_010.html ].
The maximum size for “machinable” letters at the USPS First-Class mail rate is as follows, in terms of Length X Width and thickness: 11-½″ x 6-⅛″ x ¼″ thick. When a piece of USPS First-Class Mail exceeds any one of the maximum measurements of a letter, it is classified and priced as a large envelope (flat) rate. The maximum weight for letter-size pieces at the USPS First-Class rate is 3.5 ounces (weight).
The USPS defines common nonmachinable characteristics as follows: the aspect ratio (length divided by height) is less than 1.3 or more than 2.5; the mail piece is rigid or contains odd-shaped items; the delivery address is parallel to the shorter dimension of the mail piece; the mail piece measures more than 6″ long or 4-¼″ high, if the thickness is less than 0.009″.
The non-rigid requirement for machinable First-Class mail pieces is significant. The USPS has this non-rigid requirement since the sorting machines used by the USPS have metal drums each with about a 5.5 inch radius. First-Class mail pieces are “non-rigid” if they can be bent around these metal drums and conform to their shape having this 5.5 inch radius.
A product manufacturer meeting USPS First-Class mailing requirements presents a unique set of variables to solve for shipping its products under this cost-efficient service. The set of variables is further complicated if the product manufacturer has a fluid type of product to ship. If a fluid type product needs to be shipped via USPS First-Class mail, the container holding the fluid must also meet these stringent requirements in addition to preventing any leaking of the fluid from the container.
Accordingly, there is a need in the art for a method and system for creating a fluid product mailer which meets the stringent requirements set by the USPS for its First-Class rate. Thus, there is a need in the art for a fluid product mailer which is compact and is flexible so that it is “machinable” by the USPS, or can be processed without human intervention during the mailing or sorting process.
A method and system provides a folded mailer system which can house / enclose a container which houses a liquid. The folded mailer system meets the requirements / standards as set forth by the USPS for first-class machinable mail. While the folded mailer system meets the USPS requirements / standards for first-class machinable mail, the folded mailer system may also meet the requirements / standards for machinable mail in other jurisdictions outside of the United States, such as, but not limited to, the United Kingdom, Germany, France, Spain, Italy, Netherlands, Belgium, Australia, Japan, China, Taiwan, the Russian Federation, etc. etc.
A mailer system may include a container capable of holding a liquid and a structure for holding the container when the container is shipped. The structure may have at least two sections which are folded on to each other when the container is shipped. The container and structure may be machinable within an automated mailing system.
One section of the structure may have an aperture for receiving the container. The structure may also have a third section which is folded over the first and second sections. The structure may comprise a tri-folded arrangement when the container and structure are shipped. Each section of the structure may have removable portions that are detached after the container and structure are shipped such that the container may be removed from the structure. The container may have a fluid outlet. The container may hold fluid comprising at least one of: a fragrance, a pheromone, a cosmetic treatment, a pharmaceutical composition, an insecticide or a parasiticide composition for treating an animal, including humans. The container may also have a bottom plate. The structure of the system may comprise a planar sheet. The planar sheet may comprise a plurality of layers.
According to another exemplary embodiment, the mailer system may include a folded planar member; and a container that is attached to the folded planar member. The container may enclose a fluid. The mailer system may be machinable by an automated mailing system which uses at least one drum that bends the mailer system around the drum.
The fluid within the container may comprise a topical composition for the treatment or prevention of an ectoparasitic infestation in animals. The ectoparasites comprise at least one of fleas, ticks, chewing lice, and mange. The fluid may comprise at least one of a: fragrance, pheromone, cosmetic treatment for use in companion animals or an insecticide or parasiticide.
The folded planar member may comprise a plurality of layers. One layer may comprise at least one of cardboard, varnish, and a plastic film.
According to another exemplary embodiment, a mailer system may include a folded planar member; and a container that is attached to the folded planar member. The container may enclose a fluid. The folded planar member may further comprise an aperture for receiving the container. The mailer system may be machinable by an automated mailing system which uses at least one drum that bends the mailer system around the drum.
This summary is provided to introduce a selection of concepts that are further described below in the detailed description and illustrated in the several detailed figures. This summary is not intended to identify key or essential features of the claimed subject matter, nor is it intended to be used as an aid in limiting the scope of the claimed subject matter.
In the drawings, like reference numerals refer to like parts throughout the various views unless otherwise indicated. For reference numerals with letter character designations such as “102A” or “102B”, the letter character designations may differentiate two like parts or elements present in the same figure. Letter character designations for reference numerals may be omitted when it is intended that a reference numeral to encompass all parts having the same reference numeral in all figures. For clarity, not all components are shown in each Figure.
The word “exemplary” is used herein to mean “serving as an example, instance, or illustration.” Any aspect described herein as “exemplary” is not necessarily to be construed as exclusive, preferred or advantageous over other aspects.
Referring now to
The third planar section 106 has an aperture 107 which has a shape that substantially mirrors the shape of a container 105. The container 105 may house or contain a fluid according to one exemplary embodiment. However, the container may house solids or semi-solid substances as will be described below.
When in fluid form, the fluid may comprise a topical composition for the treatment or prevention of ectoparasitic infestation and/or infection in animals (i.e. treating and/or preventing fleas, ticks, chewing lice, mange and/or nematode and filarial worms in companion animals). In one embodiment, the animal may be a companion animal. Companion animals may include, but are not limited to, dogs and cats. However, other types of dosage forms are possible and are included within the scope of this disclosure, where some are described in detail below.
Other fluids within the container 105 may comprise a fragrance for humans, a pheromone, a cosmetic treatment, an insecticide, a pharmaceutical composition, or other fluids for various uses, etc. Further, as noted above, the container 105 may envelope or house objects other than fluids. For example, the container 105 may house a soft chewable composition, pills/medicine, gels, lotions, pastes, an electronic chip such as a transponder for a companion animal, or a memory chip for a personal computing device (i.e. wireless phone, laptop, camera, etc.).
In other embodiments, the container 105 may hold other, various types of pharmaceutical compositions and dosage forms. For example, in one exemplary embodiment, the container 105 may hold pharmaceutical compositions comprising an effective amount of at least one active ingredient, or salts thereof, in combination with an acceptable carrier or diluent. The pharmaceutical compositions may be in a variety of liquid and solid forms which are suitable for various methods of application or administration to an animal.
As another example, the pharmaceutical compositions may comprise one or more active ingredients which may be in compositions suitable for oral administration, injectable administration, including subcutaneous and parenteral administration, topical administration (e.g. spot-on or pour-on), including dermal or subdermal administration. It will be understood by one of ordinary skill in the art that the shape and size of the dosage form may be adapted to be included in the container 105 of the present invention.
Suitable topical spot-on or pour-on pharmaceutical compositions may comprise a pharmaceutically effective amount of at least one active ingredient in a pharmaceutically acceptable carrier or diluent. The pharmaceutically acceptable carrier or diluent for the topical compositions may include, but are not limited to, solvents and solvent mixtures, permeation enhancers, surfactants, antioxidants, pH stabilizers, preservatives and crystallization inhibitors known in the art.
In other exemplary embodiments, the container 105 may hold a composition suitable for oral administration to an animal. Suitable dosage forms for oral administration include dietary supplements, troches, lozenges, chewables (e.g. chewable tablets or soft chews), tablets, hard or soft capsules, boluses, emulsions, aqueous or oily suspensions, aqueous or oily solutions, oral drench compositions, dispersible powders or granules, premixes, syrups or elixirs, enteric compositions or pastes. In one embodiment, a flat-rollable-chewable paste or gum for oral administration may be included in the container. The size and shape of the flat-rollable-chewable paste may be adapted to fit the size and shape of the container 105. Pharmaceutical compositions intended for oral use may be prepared according to any method known in the art for the manufacture of pharmaceutical compositions. Suitable tablets may be obtained, for example, by mixing one or more active agents with known excipients, for example inert diluents, carriers, disintegrants, adjuvants, surfactants, binders and/or lubricants.
In another exemplary embodiment of the invention, a soft chewable veterinary composition may be provided in the container 105 that comprises an effective amount of at least one active agent in a pharmaceutically acceptable carrier.
The container 105 may include a variety of active agents and combinations of active agents together with pharmaceutically acceptable carriers or diluents. In one embodiment, the active ingredient may include one or more arylpyrazole compounds, such as a phenylpyrazole insecticide known in the art. Phenylpyrazole insecticides act by blocking glutamate-activated chloride channels (GABAA gated chloride) in insects. Examples of such phenylpyrazole compounds include but are not limited to those described in U.S. Pat. Nos. 6,001,384; 6,010,710; 6,083,519; 6,096,329; 6,174,540; 6,685,954 and 6,998,131 (all incorporated herein by reference). One particular phenylpyrazole compound that may be included is fipronil.
In another embodiment of the invention, one or more macrocyclic lactones, which act as an acaricide, anthelmintic agent and/or insecticide, can be included in the container 105. Macrocyclic lactones include both avermectins and milbemycins active agents. Avermectins include, but are not limited to, abamectin, dimadectin, doramectin, emamectin, eprinomectin, ivermectin, latidectin, lepimectin and selamectin. Milbemycins include, but are not limited to, milbemectin, milbemycin D, milbemycin oxime, moxidectin and nemadectin. Also included are the 5-oxo and 5-oxime derivatives of said avermectins and milbemycins.
In another embodiment, the active agent within the container 105 may be one or more molecules of a class of insecticides known as insect growth regulators (IGRs). Compounds belonging to this group are well known to the practitioner and represent a wide range of different chemical classes. These compounds all act by interfering with the development or growth of the insect pests. Insect growth regulators are described, for example, in U.S. Pat. Nos. 3,748,356, 3,818,047, 4,225,598, 4,798,837, 4,751,225, EP 0 179 022 or U.K. 2 140 010 as well as U.S. Pat. Nos. 6,096,329 and 6,685,954 (all incorporated herein by reference).
In one embodiment, the container 105 may include an IGR that mimics juvenile hormone (juvenile hormone mimic). Examples of juvenile hormone mimics include, but are not limited to, azadirachtin, diofenolan, fenoxycarb, hydroprene, kinoprene, (S)-methoprene, pyriproxyfen, tetrahydroazadirachtin and 4-chloro-2(2-chloro-2-methyl-propyl)-5-(6-iodo-3-pyridylmethoxy)pyridazine-3(2H)-one.
In another embodiment, the IGR compound within the container 105 may comprise a chitin synthesis inhibitor. Chitin synthesis inhibitors act by interfering with the insect molting process. Chitin synthesis inhibitors include, but are not limited to, chlorofluazuron, cyromazine, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumoron, lufenuron, tebufenozide, teflubenzuron, triflumoron, novaluron, 1-(2,6-difluorobenzoyl)-3-(2-fluoro-4-(trifluoromethyl)phenylurea, 1-(2,6-difluoro-benzoyl)-3-(2-fluoro-4-(1,1,2,2-tetrafluoroethoxy)-phenylurea and 1-(2,6-difluorobenzoyl)-3-(2-fluoro-4-trifluoromethyl)phenylurea.
In yet another embodiment, an active agent within the container 105 may include one or more pyrethrin or pyrethroid adulticide insecticide and/or acaricide. These include the pyrethrins cinerin I, cinerin II, jasmolin I, jasmolin II, pyrethrin I, pyrethrin II and mixtures thereof, and the pyrethroids permethrin, cyhalothrin, cypermethrin, cyphenothrin, deltamethrin, dimefluthrin, esfenvalerate, etofenprox, fenvalerate, fenpropathrin, flucythrinate, flumethrin, imiprothrin, lambda-cyhalothrin, metofluthrin, phenothrin, prallethrin, resmethrin, silafluofen, tau-fluvalinate, tefluthrin, tetramethrin, tralomethrin and transfluthrin. Suitable carbamates include, but are not limited to, benomyl, carbanolate, carbaryl, carbofuran, meththiocarb, metolcarb, promacyl, propoxur, aldicarb, butocarboxim, oxamyl, thiocarboxime and thiofanox.
In some embodiments, the active agent included in the container 105 may be one or more antinematodal agents including, but not limited to, active agents in the benzimidazoles, imidazothiazoles, tetrahydropyrimidines, and organophosphate class of compounds. In some embodiments, benzimidazoles include, but are not limited to, thiabendazole, cambendazole, parbendazole, oxibendazole, mebendazole, flubendazole, fenbendazole, oxfendazole, albendazole, cyclobendazole, febantel, thiophanate and its o,o-dimethyl analogue.
In other embodiments, the active agent within the container 105 may be an imidazothiazole compound including, but not limited to, tetramisole, levamisole and butamisole.
In still other embodiments, the active agent within the container 105 may be a tetrahydropyrimidine active agent including, but not limited to, pyrantel, oxantel, and morantel.
Suitable organophosphate active agents that may be transported by the container 105 include, but are not limited to, coumaphos, trichlorfon, haloxon, naftalofos and dichlorvos, heptenophos, mevinphos, monocrotophos, TEPP, and tetrachlorvinphos.
In other embodiments, the active agent within the container 105 may be an antinematodal compound such as phenothiazine and piperazine as the neutral compounds, or in various salt forms; diethylcarbamazine, phenols such as disophenol, arsenicals such as arsenamide, ethanolamines such as bephenium, thenium closylate, and methyridine; cyanine dyes including pyrvinium chloride, pyrvinium pamoate and dithiazanine iodide; isothiocyanates including bitoscanate, suramin sodium, phthalofyne, and various natural products including, but not limited to, hygromycin B, α-santonin and kainic acid.
In other embodiments, the container 105 may include an antitrematodal agent. Suitable antitrematodal agents include, but are not limited to, the miracils such as miracil D and mirasan; praziquantel, clonazepam and its 3-methyl derivative, oltipraz, lucanthone, hycanthone, oxamniquine, amoscanate, niridazole, nitroxynil, various bisphenol compounds known in the art including hexachlorophene, bithionol, bithionol sulfoxide and menichlopholan; various salicylanilide compounds including tribromsalan, oxyclozanide, clioxanide, rafoxanide, brotianide, bromoxanide and closantel; triclabendazole, diamfenetide, clorsulon, hetolin and emetine.
Anticestodal compounds may also be included in the container 105 including, but not limited to, arecoline in various salt forms, bunamidine, niclosamide, nitroscanate, paromomycin and paromomycin II.
In yet other embodiments, the container 105 may include active agents that are effective against arthropod parasites. Suitable active agents include, but are not limited to, bromocyclen, chlordane, DDT, endosulfan, lindane, methoxychlor, toxaphene, bromophos, bromophos-ethyl, carbophenothion, chlorfenvinphos, chlorpyrifos, crotoxyphos, cythioate, diazinon, dichlorenthion, diemthoate, dioxathion, ethion, famphur, fenitrothion, fenthion, fospirate, iodofenphos, malathion, naled, phosalone, phosmet, phoxim, propetamphos, ronnel, stirofos, allethrin, cyhalothrin, cypermethrin, deltamethrin, fenvalerate, flucythrinate, permethrin, phenothrin, pyrethrins, resmethrin, benzyl benzoate, carbon disulfide, crotamiton, diflubenzuron, diphenylamine, disulfiram, isobornyl thiocyanato acetate, methoprene, monosulfiram, pirenonylbutoxide, rotenone, triphenyltin acetate, triphenyltin hydroxide, deet, dimethyl phthalate, and the compounds 1,5a,6,9,9a,9b-hexahydro-4a(4H)-dibenzofurancarboxaldehyde (MGK-11), 2-(2-ethylhexyl)-3a,4,7,7a-tetrahydro-4,7-methano-1H-isoindole-1,3(2H)dione (MGK-264), dipropyl-2,5-pyridinedicarboxylate (MGK-326) and 2-(octylthio)ethanol (MGK-874).
Another antiparasitic agent that may be included in the container 105 includes a biologically active peptide or protein including, but not limited to, cyclic depsipeptides, which act at the neuromuscular junction by stimulating presynaptic receptors belonging to the secretin receptor family resulting in the paralysis and death of parasites. In one embodiment, the cyclic depsipeptide is an octacyclodepsipeptide such as emodepside or PF1022A(see Willson et al., Parasitology, January 2003, 126(Pt 1):79-86). In another embodiment, the cyclooctadepsipeptides is an active agent described in U.S. Pat. Nos. 10,081656 and 10,344,056 (both incorporated herein by reference).
In another embodiment, an active agent from the neonicotinoid class of pesticides may be included in the container 105. The neonicotinoids bind and inhibit insect specific nicotinic acetylcholine receptors. In one embodiment, the neonicotinoid insecticidal agent is imidacloprid. Imidacloprid is a well-known neonicotinoid active agent and is the key active ingredient in the topical parasiticide products Advantage®, Advantage® II, K9 Advantix®, and K9 Advantix® II sold by Elanco Animal Health. Agents of this class are described, for example, in U.S. Pat. No. 4,742,060 or in EP 0 892 060 (incorporated herein by reference).
In another embodiment, the neonicotinoid active agent transported by the container 105 is nitenpyram. Nitenpyram is the active ingredient in the oral product CAPSTAR™ Tablets sold by Novartis Animal Health. Nitenpyram is active against adult fleas when given daily as an oral tablet. Nitenpyram works by interfering with normal nerve transmission and leads to the death of the insect. Nitenpyram has a very fast onset of action against fleas. For example, CAPSTAR™ Tablets begin to act against fleas in as early as 30 minutes after administration and is indicated for use as often as once a day.
In another embodiment, an insecticidal agent that can be included in the container 105 of the invention is a semicarbazone, such as metaflumizone.
In another embodiment, an isoxazoline compound known in the art may be included in the container 105. These isoxazoline active agents are described in US 7,964,204, US 8,410,153, US 2011/0152312, US 2010/0254960 A1, US2011/0159107, US2012/0309620, US2012/0030841, US2010/0069247, WO 2007/125984, WO 2012/086462, US 8,318,757, US 2011/0144349, US 8,053,452; US 2010/0137612, US 2010/0254959, US 2011/152081, WO 2012/089623, WO 2012/089622, US 8,119,671; US 7,947,715; WO 2102/120135, WO 2012/107533, WO 2011/157748, US 2011/0245274, US 2011/0245239, US 2012/0232026, US 2012/0077765, US 2012/0035122, US 2011/0251247, WO 2011/154433, WO 2011/154434, US 2012/0238517, US 2011/0166193, WO 2011/104088, WO 2011/104087, WO 2011/104089, US 2012/015946, US 2009/0143410, WO 2007/123855 A2, US 2011/0118212, US7951828 & US7662972, US 2010/0137372 A1, US 2010/0179194 A2, US 2011/0086886 A2, US 2011/0059988 A1, US 2010/0179195 A1, US 7,897,630, U.S. 7,951,828 and US 7,662,972, all of which are incorporated herein by reference in their entirety.
Isoxazoline compounds that may be transported by the container 105 include, but are not limited to, afoxolaner, esafoxolaner, umifoxolaner, fluralaner, sarolaner and lotilaner.
In another embodiment of the invention, nodulisporic acid and its derivatives (a class of known acaricidal, anthelmintic, anti-parasitic and insecticidal agents) may be included in the container 105. These compounds are used to treat or prevent infections in humans and animals and are described, for example, in U.S. Pat. No. 5,399,582, 5,962,499, 6,221,894 and 6,399,786, all of which are hereby incorporated by reference in their entirety.
In another embodiment, anthelmintic compounds of the amino acetonitrile class (AAD) of compounds such as monepantel (ZOLVIX), and the like, may be included in the container 105. These compounds are described, for example, in WO 2004/024704 and U.S. Pat. No. 7,084,280 (incorporated by reference); Sager et al., Veterinary Parasitology, 2009, 159, 49-54; Kaminsky et al., Nature vol. 452, 13 Mar. 2008, 176-181.
The container 105 of the invention may also include aryloazol-2-yl cyanoethylamino compounds such as those described in U.S. Pat. No. 8,088,801 to Soll et al., which is incorporated herein by reference, and thioamide derivatives of these compounds, as described in U.S. Pat. No. 7,964,621, also incorporated herein by reference.
Paraherquamide compounds and derivatives of these compounds, including derquantel (see Ostlind et al., Research in Veterinary Science, 1990, 48, 260-61; and Ostlind et al., Medical and Veterinary Entomology, 1997, 11, 407-408) may also be included in the container 105. The paraherquamide family of compounds is a known class of compounds that include a spirodioxepino indole core with activity against certain parasites (see Tet. Lett. 1981, 22, 135; J. Antibiotics 1990, 43, 1380, and J. Antibiotics 1991, 44,492). In addition, the structurally related marcfortine family of compounds, such as marcfortines A-C, are also known and may be combined with the formulations of the invention (see J. Chem. Soc. - Chem. Comm. 1980, 601 and Tet. Lett. 1981, 22, 1977). Further references to the paraherquamide derivatives can be found, for example, in WO 91/09961, WO 92/22555, WO 97/03988, WO 01/076370, WO 09/004432, U.S. Pat. 5,703,078 and U.S. Pat. 5,750,695, all of which are hereby incorporated by reference in their entirety.
In a particular embodiment, the container 105 may have a combination of the phenylpyrazole fipronil and (S)-methoprene. This combination of active agents is present in the companion animal treatment product Frontline® Plus, sold as of this writing.
In another embodiment, the container 105 may have a combination of fipronil, (S)-methoprene and pyriproxyfen. This combination of active agents is present in the companion animal treatment product Frontline® Gold for dogs, sold as of this writing.
In another embodiment, the container 105 may have a combination of the phenylpyrazole active agent fipronil, permethrin and pyriproxyfen. This combination of active agents is present in the companion animal treatment product Frontline® Shield for dogs, sold as of this writing.
In another embodiment, the container 105 may have a combination of the phenylpyrazole fipronil and permethrin. This combination of active agents is present in the companion animal treatment products Frontline Tri-Act®/Frontect® sold as of this writing.
The container 105 is removable from the aperture 107 in the third section 106. The container 105 is releasably fastened to the front side 104a of the second section 104 by using peelable gel glue or other equivalent fastening method as understood by one of ordinary skill in the art.
In the perspective view of
Each section 102, 104, 106 may further comprise writings comprising alpha -numeric human-readable text as well as machine-readable elements (i.e. 2-D Bar-Codes). The human-readable text/characters and/or machine-readable elements may further describe the contents of the container 105 and/or how the contents of the container 105 may be used by the consumer.
Referring now to
In
The sections 202 containing the adhesive are generally removed from the mailer system 101 after the mailer system 101 has been transported or shipped to the consumer. As noted above, the sections 202 containing the adhesive may be removed along the cut or dashed lines shown in
The curved edge 127 of
Referring now to
Each rear side 102b, 104b, and 106b of each section 102, 104, 106 may have unique and different human-readable alpha-numeric text as well as machine-readable elements, similar to the front sides 102a, 104a, 106a. The elements may include a postal address and a stamp or us postal permit either directly printed on the mailer, or printed on a paper label affixed to the mailer with the use of adhesives. The text and/or machine-readable elements of rear sides 102b, 104b, 106b may be different, similar, and/or identical to that information presented on the opposite sides 102a, 104a, 106a.
Referring now to
As noted previously, the sizes and/or geometry of the mailer system 101 should adhere to the “machinable” requirements set by the USPS for First-Class mail rates. While the mailer system 101 meets the USPS requirements / standards for first-class machinable mail, the mailer system 101 may also meet the requirements / standards for machinable mail in other jurisdictions outside of the United States, such as, but not limited to, the United Kingdom, Germany, France, Spain, Italy, Netherlands, Belgium, Australia, Japan, China, Taiwan, the Russian Federation, etc. etc.
Referring now to
The container 105 may also comprise alpha-numeric text and/or machine readable elements 504. The text and/or elements 504 may comprise brand information such as a trademark or tradename. The container may further comprise an outlet 502 that may allow liquid (not visible) in the container 105 to exit, once an edge of the outlet 502 is cut and/or removed.
As illustrated in
Referring now to
As such, the height of the container 105 usually must be less than one-quarter (¼) inch to allow for the mailer cardboard thickness above and below the container 105. However, other sizes smaller or larger are possible and are within the scope of this disclosure. Other sizes which are greater may take the container 105 outside of the U.S. First-Class requirements, but this may be acceptable in certain circumstances when U.S. First-Class mailings are not desired and/or the container is being shipped/mailed outside of the U.S. where the First-Class requirements are not being followed by a non-U.S. jurisdiction. For example, these other jurisdictions may not be concerned with the U.S. First-Class requirements: the United Kingdom, Germany, France, Spain, Italy, Netherlands, Belgium, Australia, Japan, China, Taiwan, the Russian Federation, etc. etc.
Referring now to
And more specifically, top section 604 may comprise a plurality of layers, such as, but not limited to, the following layers in this exemplary order: (Exterior ambient air next to container 105) > Polypropylene - cyclo olefin copolymer -Polypropylene/Polyethylene - Ethylene vinyl alcohol - Polyethylene > (where the Polyethylene layer is the innermost layer which contacts the liquid within the container 105). An abbreviation for the multi-layer structure for top section 604 is as follows: PP-COC-PP/PE-EVOH-PE. However, other materials and combinations of materials are possible and included within the scope of this disclosure.
The bottom section 606, like the top section 604, may also comprise a multi-layered structure. And more specifically, bottom section 604 may comprise a plurality of layers, such as, but not limited to, the following layers in this exemplary order: (exterior ambient air outside of container 105) > Printed Ink > Polyethylene Terephthalate / Aluminum / Polyethylene - Ethylene vinyl alcohol - Polyethylene > (where the Polyethylene layer is the innermost layer which contacts the liquid within the container 105). An abbreviation for the multi-layer structure for bottom section 606 is as follows: PET/Alu/PE-EVOH-PE. However, other materials and combinations of materials are possible and included within the scope of this disclosure.
Referring now to
Referring now to
Specifically, this figure shows how the mailer system 101 deflects around a drum 800 when the mailer system 101 flows through an automated mail sorting system. According to one exemplary embodiment, the drum 800 has a radius of approximately 5.5 inches, as set forth by the USPS.
As understood by one of ordinary skill in the art of automated mail sorting systems, to ensure transport through automated mail processing machines, a mail piece and its contents usually must bend easily when subjected to a transport belt tension of about 40.0 pounds around an 11.0 inch-diameter drum. This means, for U.S. mailings, the bend radius is generally 5.5 inches or greater. 5.5 inches is equal to about 140.0 mm. In Europe, each drum may be about 280.0 mm in diameter (i.e. Siemens brand sorting machines) or about 300.0 mm in diameter (i.e. Neopost sorting machines).
Other radii are possible and are included within the scope of this disclosure. Other radii may be larger or smaller than those depicted as understood by one of ordinary skill in the art.
Referring now to
However, other sizes smaller or larger are possible and are within the scope of this disclosure. Other sizes which are greater may take the container 105 outside of the U.S. First-Class requirements, but this may be acceptable in certain circumstances when U.S. First-Class mailings are not desired and/or the container is being shipped/mailed outside of the U.S. where the First-Class requirements are not being followed by a non-U.S. jurisdiction.
Referring now to
Also, a cut line 1015 may have a curved shape. However, in other exemplary embodiments, the cut line 1015 may have another shape such as straight, or other shapes as needed as understood to one of ordinary skill in the art.
Referring now to
Referring now to
In
Referring now to
In this figure, relative to the view of
Referring now to
In this
The mailer systems 101, 101′ of
Referring now to
In this
Referring now to
Relative to
Referring now to
In this
Referring now to
In
Referring now to
In
Referring now to
In this
As but one example, two layers are shown in each of
In the multi-layer embodiments, such as illustrated in
In the multi-layer embodiments, such as illustrated in
Referring now to
Referring now to
Referring now to
As understood by one of ordinary skill in the art, the mailer system 101 could be formed by folding a sheet in any number of folds as well as without any folding. That is, the system 101 could be formed as a bi-fold (two-folded) system 101. Alternatively, the system 101 could be formed as a quad-fold (four-folded) system as well, and so-on. And it follows that the system 101 may also work without any folds (single sheet - no folds) as understood by one of ordinary skill in the art.
In step 2605, perforation lines 1005, 1015, and 1020 are formed within the system 101 as illustrated in
Subsequently, in second step 2610 of
Next, in third step 2615, the third section 106 of the tri-fold mailer system 101 is folded along the fold line 1022b such that the aperture 107 aligns with the perimeter of the container 105, as illustrated in
Subsequently, in the fourth step 2620 of
Next, in step 2625 of
The sections 102, 104, 106 and container 105 of the system 101 have a predetermined flexibility such that they may be bent around the drum 800 as described above. Thus, in this fifth step 2625 of method 2600, the mailer systems 101, 101′ are flexible or bendable around drums 800 illustrated in
Subsequently, in the sixth step 2630, the mailer system 101 has been received by the consumer located at the mailing address 1404 (seen in
Next, in the seventh step 2635, the third section 102a of the tri-fold as illustrated in
In the eighth step 2640, the third section 106a may be “opened-up” by unfolding that section 106a along fold line 1022b as illustrated in
Next, in the ninth step 2645, the container 105 may be removed from the second section 104a of the folded mailer system 101 as illustrated with the dashed-double-headed arrow presented in
Referring now to
Referring now to
Additionally, certain steps in the processes or process flows enabled by the mechanical drawings in this specification naturally precede others for the invention to function as described. However, the invention is not limited to the order of the steps described if such order or sequence does not alter the functionality of the invention. That is, it is recognized that some steps may performed before, after, or parallel (substantially simultaneously with) other steps without departing from the scope and spirit of the invention. In some instances, certain steps may be omitted or not performed without departing from the invention.
The materials for the parts illustrated in the several figures may include various types of polymers/plastics like silicone as well as compostable plant based resin films. Other plastics than those described above may be employed without departing from the scope of this disclosure. Further, other materials besides plastics are also possible and are included within the scope of this disclosure. Other materials besides plastics include, but are not limited to, composite materials, and any combination thereof.
Although a few embodiments have been described in detail above and illustrated in the several figures, those skilled in the art will readily appreciate that many modifications from those which were described and as illustrated are possible in the embodiments without materially departing from this disclosure. Accordingly, such modifications are intended to be included within the scope of this disclosure as defined in the following claims.
For example, while several mechanical configurations are illustrated in
Similarly, in the claims, means-plus-function clauses are intended to cover the structures described herein as performing the recited function and not only structural equivalents, but also equivalent structures. Thus, although a nail and a screw may not be structural equivalents in that a nail employs a cylindrical surface to secure wooden parts together, whereas a screw employs a helical surface, in the environment of fastening wooden parts, a nail and a screw may be equivalent structures.
It is the express intention of the applicant not to invoke 35 U.S.C. § 112, sixth paragraph for any limitations of any of the claims herein (or in future cases), except for those in which the claim expressly uses the words ‘means for’ together with an associated function.
The following numbered clauses are also part of the disclosure and are comprised by the spirit and scope of the present invention:
1. A mailer system comprising:
2. The system of clause 1, wherein one section of the structure has an aperture for receiving the container.
3. The system of clauses 1 or 2, wherein the structure comprises a third section which is folded over the first and second sections.
4. The system of any of clauses 1 to 3, wherein the structure comprises a tri-folded arrangement when the container and structure are shipped.
5. The system of any of clauses 1 to 4, wherein each section has removable portions that are detached after the container and structure are shipped such that the container may be removed from the structure.
6. The system of any of clauses 1 to 5, wherein the container has a fluid outlet.
7. The system of any of clauses 1 to 6, wherein the container holds a fluid comprising at least one of:
a fragrance, a pheromone, a cosmetic treatment, an insecticide, a parasiticide, and a pharmaceutical compound for treating an animal or a human.
8. The system of any of clauses 1 to 7, wherein the container has a bottom plate.
9. The system of any of clauses 1 to 8, wherein the structure comprises a planar sheet.
10. The system of any of clauses 1 to 9, wherein the planar sheet comprises a plurality of layers.
11. A mailer system comprising:
12. The system of clause 11, wherein the dosage form comprises a topical composition for the treatment or prevention of an ectoparasitic infestation in animals.
13. The system of clause 11 or 12, wherein the ectoparasites comprise at least one of fleas, ticks, chewing lice, and mange.
14. The system of any of clauses 11 to 13, wherein the dosage form comprises at least one of: a fragrance, a pheromone, a cosmetic treatment, an insecticide, and a pharmaceutical.
15. The system of any of clauses 11 to 14, wherein the folded planar member comprises a plurality of layers.
16. The system of any of clauses 11 to 15, wherein one layer comprises at least one of cardboard, varnish, and a plastic film.
17. A mailer system comprising:
18. The system of clause 17, wherein the dosage form comprises a topical composition for the treatment or prevention of an ectoparasitic infestation in animals.
19. The system of clause 17 or 18, wherein the ectoparasites comprise at least one of fleas, ticks, chewing lice, and mange.
20. The system of any of clauses 17 to 19, wherein the dosage form comprises at least one of: a fragrance, a pheromone, a cosmetic treatment, an insecticide, and a pharmaceutical.
Although selected aspects have been illustrated and described in detail, it will be understood that various substitutions and alterations may be made therein without departing from the spirit and scope of the present invention, as defined by the following claims.
This application claims the benefit of priority to U.S. Provisional Application No. 63/268,148 filed on Feb. 17, 2022, which is incorporated herein by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
63268148 | Feb 2022 | US |